Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Immunity Bio, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $107 Billion
- Q1 2025
Shares
5 transactions
Others Institutions Holding IBRX
# of Institutions
253Shares Held
80.7MCall Options Held
1.25MPut Options Held
2.73M-
Vanguard Group Inc Valley Forge, PA20.3MShares$52.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$29.2 Million0.0% of portfolio
-
State Street Corp Boston, MA7.58MShares$19.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.29MShares$11 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$8.82 Million0.07% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.02B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...